Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Marler

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Stroke|September 1, 1996
Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart AssociationH P Adams, T G Brott, A J Furlan, et al.
Circulation|September 1, 1996
Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart AssociationH P Adams, T G Brott, A J Furlan, et al.
Annals of Neurology|June 21, 2001
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic strokeJ Broderick, M Lu, C Jackson, et al.
Neurology|May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupS C Fagan, L B Morgenstern, A Petitta, et al.
JAMA|June 24, 2000
Recommendations for the establishment of primary stroke centers. Brain Attack CoalitionM J Alberts, G Hademenos, R E Latchaw, et al.
Stroke|July 1, 1997
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Acute interventionsM S Pessin, H P Adams, R J Adams, et al.
Neurology|December 13, 2000
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke studyJ R Marler, B C Tilley, M Lu, et al.
JAMA|December 12, 2001
Lack of clinical significance of early ischemic changes on computed tomography in acute strokeS C Patel, S R Levine, B C Tilley, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Stroke|September 1, 1996
Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart AssociationH P Adams, T G Brott, A J Furlan, et al.
Circulation|September 1, 1996
Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart AssociationH P Adams, T G Brott, A J Furlan, et al.
Annals of Neurology|June 21, 2001
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic strokeJ Broderick, M Lu, C Jackson, et al.
Neurology|May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupS C Fagan, L B Morgenstern, A Petitta, et al.
JAMA|June 24, 2000
Recommendations for the establishment of primary stroke centers. Brain Attack CoalitionM J Alberts, G Hademenos, R E Latchaw, et al.
Stroke|July 1, 1997
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Acute interventionsM S Pessin, H P Adams, R J Adams, et al.
Neurology|December 13, 2000
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke studyJ R Marler, B C Tilley, M Lu, et al.
JAMA|December 12, 2001
Lack of clinical significance of early ischemic changes on computed tomography in acute strokeS C Patel, S R Levine, B C Tilley, et al.
Pageof 5